A detailed history of Geode Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 113,581,638 shares of PFE stock, worth $3.25 Billion. This represents 0.29% of its overall portfolio holdings.

Number of Shares
113,581,638
Previous 109,534,217 3.7%
Holding current value
$3.25 Billion
Previous $3.15 Billion 0.05%
% of portfolio
0.29%
Previous 0.33%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $105 Million - $120 Million
4,047,421 Added 3.7%
113,581,638 $3.15 Billion
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $64 Million - $83.1 Million
2,448,393 Added 2.29%
109,534,217 $3.15 Billion
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $186 Million - $217 Million
-5,786,682 Reduced 5.13%
107,085,824 $3.55 Billion
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $109 Million - $126 Million
3,019,727 Added 2.75%
112,872,506 $4.14 Billion
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $22.7 Million - $29.6 Million
577,201 Added 0.53%
109,852,779 $4.48 Billion
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $48.7 Million - $63.6 Million
-1,166,562 Reduced 1.06%
109,275,578 $5.59 Billion
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $81.4 Million - $99.3 Million
1,859,302 Added 1.71%
110,442,140 $4.83 Billion
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $171 Million - $203 Million
3,684,436 Added 3.51%
108,582,838 $5.68 Billion
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $175 Million - $217 Million
3,833,329 Added 3.79%
104,898,402 $5.42 Billion
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $60.8 Million - $90.2 Million
1,471,980 Added 1.48%
101,065,073 $5.95 Billion
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $126 Million - $162 Million
3,211,904 Added 3.33%
99,593,093 $4.27 Billion
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $80.2 Million - $90.8 Million
2,233,072 Added 2.37%
96,381,189 $3.76 Billion
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $124 Million - $140 Million
3,699,308 Added 4.09%
94,148,117 $3.4 Billion
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $41.3 Million - $52.6 Million
1,235,353 Added 1.38%
90,448,809 $3.32 Billion
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $2.23 Million - $2.62 Million
70,293 Added 0.08%
89,213,456 $3.27 Billion
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $24.4 Million - $29.6 Million
-810,722 Reduced 0.9%
89,143,163 $2.91 Billion
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $24.6 Million - $35.1 Million
910,123 Added 1.02%
89,953,885 $2.93 Billion
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $53.7 Million - $60.9 Million
1,630,039 Added 1.86%
89,043,762 $3.48 Billion
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $75.8 Million - $98.3 Million
2,332,421 Added 2.74%
87,413,723 $3.14 Billion
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $39.6 Million - $44.4 Million
1,070,454 Added 1.27%
85,081,302 $3.68 Billion
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $330 Million - $363 Million
8,801,937 Added 11.7%
84,010,848 $3.56 Billion
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $271 Million - $309 Million
7,055,791 Added 10.35%
75,208,911 $3.28 Billion
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $48.3 Million - $58.6 Million
1,402,589 Added 2.1%
68,153,120 $3 Billion
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $4.87 Million - $5.19 Million
-147,749 Reduced 0.22%
66,750,531 $2.42 Billion
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $120 Million - $140 Million
3,774,503 Added 5.98%
66,898,280 $2.37 Billion
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $62.6 Million - $66.4 Million
1,881,570 Added 3.07%
63,123,777 $2.28 Billion
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $45.6 Million - $50.3 Million
1,472,358 Added 2.46%
61,242,207 $2.18 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
59,769,849
59,769,849 $2 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $161B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.